Strategic Alliance Partners
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
2
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
3
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
4
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
5
.png "Optometry Times"){kind=logo}
